Skip to content
Home/Companies/Biotech/Nuevolution

Nuevolution

Biotech·Denmark·Exited 2019·Held 12yr
Entry
2007
Hold
12yr
Exit
2019

Who owns Nuevolution?

Nuevolution is a Danish Biotech company, now owned by Amgen, which acquired it in 2019 from Sunstone Life Science Ventures.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Amgen
Exit Year
2019

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to Swedish Growth Fund
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011
to Eurazeo

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Nuevolution?

Nuevolution is now owned by Amgen, which acquired it in 2019 from Sunstone Life Science Ventures.

When did Amgen acquire Nuevolution?

Amgen acquired Nuevolution in 2019, buying from Sunstone Life Science Ventures.

Who did Nuevolution sell to?

Sunstone Life Science Ventures sold Nuevolution to Amgen in 2019 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue